In patients with oral cancer, local and systemic higher levels of pro-inflammatory cytokines TNF-alpha, IL-6 and IL1-beta may contribute to tumor progression leading to a poor prognosis of the disease [60,61]. This evidence concerns the gene IL6 and neoplasm.